Take advantage of our 60 years of global pharmaceutical development and manufacturing services experience. Work hand-in-hand using proven inhalation, transdermal, oral and topical manufacturing expertise from feasibility to market – all while ensuring the highest standards of manufactured product delivery in drug delivery systems.
AbbVie Contract Manufacturing has a portfolio of state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. For more than 30 years, AbbVie Contract Manufacturing has offered contract manufacturing services that spans biologics, potent, drug product, prefilled syringes, fermentation, as well as selling high quality
active pharmaceutical ingredients (APIs).
Eighty years of experience, three generations of pharmacists. Its tradition was passed down over the years, from father to son. ABC was founded in 1925 in Turin, where it manufactures finished pharmaceutical and cosmetic products. ABC INTERNATIONAL PHARMA, the International Division, was established in 1998 and is present on the international market with pharmaceutical, nutraceutical, dermocosmetic and generic finished products. ABC offers products based on highly selected; active principles, manufactured by means of new technologies, including slow and fast release, gastro-protection devices and liquid products in monodose vials with tank caps.
Abiogen Pharma S.p.A. Italy offers: licensing out opportunities from its
own product portfolio, Clinical Supply, Contract Development and Manufacturing
A state of the art facility, a strong knowledge and expertise acquired over many years of development and manufacturing of pharmaceuticals, guarantees Clients and Partners high quality standards services.
Accent Microcell Pvt. Ltd. can be signified as one of the most prestigious name in pharmaceutical industry which was founded in 2001 be a very young and dynamic group of young promoters having rich experience in pharmaceutical field. The company is known for its immense expertise in manufacturing and supplying of excipient.
Pharmacopoeia: USP/NF, JP, PH.EUR, BP, EP.
Accent Microcell can be proclaimed as one of the most distinguished Pharma Company with world-wide presence. The noteworthy features of Accent, which resulted to the escalation of customer base is our supreme quality and high end products. The secret behind the popularity of the products are that we are optimist to provide the best quality of the product. Accent Microcell is always ready to walk those extra miles to bring a smile to their customers and this dedication and professionalism has paved the way to reach the zenith in a limited span of time.
Established over 50 years ago, the ACG group is the world's only integrated pharma manufacturing solutions company absolutely committed to delivering exceptional solutions to the global pharmaceutical industry. The company's four business units—ACG Capsules, ACG Films & Foils, ACG Engineering and ACG Inspection—work synergistically to offer a complete range of pharma solutions. These solutions include empty hard capsules, granulation machines, capsule filling machines, tableting and tablet coating machines, packaging films, blister packing and carton packing machines, vision inspection machines and track & trace systems.
ACME is a
leading manufacturer of Tablets, Capsules, Injectables, Oral Contraceptives
& Levothyroxine Tabs.
Our sites are approved by EU GMP, UK-MHRA, PICS, INVIMA, ANVISA, FDA Philippines, DAV Vietnam Ethiopia, Tanzania, WHO Geneva. Triggered: TGA Australia, Health Canada and US FDA by filing planned in Q1 2018.
CTD Dossiers for Licensing
Contract Manufacturing Services
Contract Development& Research
Asia: Nepal, Sri Lanka, Philippines, Vietnam, Cambodia, Laos, Thailand, Yemen, Myanmar
Africa: Ethiopia, Nigeria, Ghana, Tanzania, Kenya, Uganda, Zambia, Malawi, Nigeria, Sierra Leone, Madagascar, Angola, Zimbabwe, Mozambique, Cameroon, Senegal, South Sudan
North America: US & Canada (Filing planned in Q1 2018)
Europe: United Kingdom, Hungary
South America: Brazil, Colombia, Guatemala, Nicaragua, Paraguay, Uruguay, Chile, Costa Rica, Venezuela, Peru
CIS: Kazakhstan, Uzbekistan, Ukraine
Responsibility of product patents lies with the buyer of the country
For more details please visit our website: www.acmeformulation.com& www.immacule.in
Aconitum - fully integrated pharmaceutical manufacturer founded in 1999 and located in Lithuania, EU. Aconitum product portfolio: biosimilars, herbal medicines, generics, homeopathic medicines, food supplements and veterinary products. Since 2009 the company operates in a modern manufacturing plant which contains GMP certified microbiology and chemical laboratories. Aconitum quality standarts: GMP for medicine production, HACCP for food supplement production and HALAL for production for Islamic countries. Aconitum has his own Innovation department in which qualified professionals together with European scientists develop new product compositions based on the newest scientific researches. Aconitum offers: products for distribution, contract manufacturing, CTD dossier out -licensing. Customers in more than 45 countries trust Aconitum as their product development and manufacturing partner.
ACS DOBFAR, a privately held Italian company founded in 1973, is a fully integrated manufacturer of Cephalosporin and Penicillin APIs as well as Finished Dosage Formulations. With production sites around the world regularly inspected by US FDA, it is a leading company among exporters to the US market.
Adamed Group is one of the leading pharmaceutical enterprises in Poland. The activities in which we are involved include: innovative molecules research, generic dossier development, manufacturing and sales of branded products across Europe. Adamed Group concentrates its activities in cardiology, CNS, gynecology and pulmonology enlarging its interest in new areas like ophthalmology, oncology etc. We are dedicated to quality and efficacy of our products, at the same time we take every effort to support our patients with the therapies which are affordable.
is a global specialty pharmaceutical company inspired to create new
possibilities for patients whose treatment needs are not fully addressed by
With a growing pipeline, focused R&D efforts, and global manufacturing capabilities, Adare is actively exploring value creation through development and expansion across therapeutic areas. Adare has a proven track record from concept through commercialization that can help you overcome formulation challenges and add valuable IP to your current and future products.
Formulation challenges? Experience a partnership focused on the needs of patients and your company's goals, contact us at [email protected]
Protexin are dedicated to producing innovative research based products of the highest quality for animals and humans.
Our belief is that nature is an ideal source of effective healthcare solutions, and that applied research and understanding can harness these solutions to the benefit of both humans and animals. We also know that too much refining of natural elements can reduce their effectiveness. That's why all products that carry the Protexin name are developed under our guiding philosophy – science and nature in balance.
In practice this means that the natural healthcare and probiotic supplements we manufacture are extensively researched for safety and efficacy. We work closely with leading universities, hospitals and research centres around the world on a range of ongoing research programmes. We are always looking to improve our products, but never compromise on their natural basis.
The Aenova Group is one of the leading contract manufacturers of pharmaceuticals, medical devices, veterinary medicinal products, dietary supplements, cosmetics and nutricosmetics. The group's portfolio of services covers the entire value chain for the development and production of finished dosage forms and product groups in the field of medicines and dietary supplements.
We offer our customers a competent service that covers the galenical and analytical development of products, the optimization of formulation concepts, manufacturing and packaging, right up to support for the certification process. Thereby we are always looking for ways to increase efficiency when it comes to material procurement, production, packaging, logistics, and distribution. We offer our customers tailored solutions for almost every dosage form including Solids, Semi-solids and Liquids. Apart from conventional manufacturing, we offer specialized capacities for aqueous and organic granulation, aqueous and organic coating of pellets and tablets, aseptic manufacturing and Lyophilization. For the handling of a wide range of high potent and cytotoxic APIs, we employ Isolator technology and personal protective equipment. Dedicated facilities are used for manufacturing Beta Lactam oral and sterile dosage forms.
The Aenova Group's high standards of quality, innovative technologies and clear vision for the future have enabled it to become European market leader in the business-to-business field.
The company, which has its headquarters near Munich, operates 20 sites in seven countries throughout the world. All sites are equipped with state-of-the-art technologies and hold all relevant manufacturing licenses and certificates. More than 4000 employees contribute to the group's success.
Ahn-Gook Pharmaceutical Co., Ltd. is a leading pharmaceutical company in Korea, we're especially strong to Repiratory system and Cardiovascular disease.
Our product, Synatura Syrup is a new drug and No. 1 of antitussive products in Korea, we're already under registration over the 10 countries.
We are accululating core technology to develop new world-class medicine and fostering key manpower that can develop and market our new products.
Ain Medicare Sdn Bhd is a leading manufacturer of sterile pharmaceutical products, ranging from intravenous infusions, anti microbial infusions, small volume injections, eye drops, sterile irrigation solutions, haemodialysis concentrates, continuous renal replacement therapy, and peritoneal dialysis solutions. Besides manufacting our own brands, AIN Medicare also provides contract manufacturing for other companies.
Founded more than 50 years
ago, AET today is one of the major service companies for the innovative as well
as generic pharmaceutical industry. AET's high quality drug developments are
marketed in all continents and in more than 60 countries.
Alkaloid AD Skopje is a generic company located in Macedonia. Our manufacturing sites are EU-GMP certified and dedicated to the production of oral solid dosage forms, liquids and oral cephalosporins. Alkaloid is one of the major- branded generic players in the Balkan region and also present with its brands in EU, Russia and CIS countries. Our product portfolio mainly consists of CVS, CNS, Cephalosporin antibiotics, Narcotics and OTCs. Alkaloid offers dossiers for out-licensing, supply and also transfer of granted MAs ready to market mainly in EU countries and CIS. We are also open for potential co-development and contract manufacturing projects.
Almediko Healthcare founded in the year 1999 has become one of the leading companies among Turkish health care sector in innovation and manufacturing of novel healthcare products. Our Vision is to go beyond the expectation of the customer.Almediko's novel and innovative products are a result of extensive research backed by clinical trials and literatüre studies and supported by the most famous Turkish Universities.At Almediko, we target to find effective solutions to the most common problems which have not been efficiently addressed by existing conventional medicines.We continuously strive to stand out with our innovative formulas, technology and products. We are committed to work towards a more healthier society with our most effective, safe to use and innovative products.Almediko is growing at very fast pace in international business volume by adopting commercial sense of mutual understanding and strategic planning with its partners and distributors through its experienced staff and professional management. We are looking for strategic partners all around the world.
Alpaya Dermaceuticals is a renowned manufacturer and exporter company of Natural Skin Care, Hair Care Products and Medical Devices based in Turkey in the pharmacies, drug chains and beauty stores with premium product lines such as Bio Balance for skin care, Forscar for scar treatment, Nutrigrow for hair care (in particular alopecia), Acnevit against Acne and Episiva against unwanted facial and body hair. ALPAYA is now present in more than 46 countries mainly in the Middle East, Africa, South America and Europe. Our products meet the requirements of European Cosmetics Directive EC1223/2009.ALPAYA was ranked as the 35th largest exporter in the skin care products category in Turkey by Turkish Exporters Association. Bio Balance's New Back To Nature Series, which is the core business of Alpaya, explores the synergistic effects of vitamins, herbal extracts, and minerals and uses them only in the right amounts and the right combinations, which are more effective than their natural form. The Unique formula of Bio Balance recovers damages caused by environmental conditions and premature aging. Bio Balance Probiotics is our newest line which we have launched after three years of in-depth research. This range is especially formulated to prevent and correct the damage caused by environmental aggressors such as pollution, UV radiation, smoke and stress. Just like our other product lines, Probiotics also contain the right amounts of star ingredients like 2% Matrixly and 2% Majestem and enriched with the Acetly Dipeptide-1, Inositol, Porcelain Flower and two types of Hyaluronic Acid (with very low molecular weights) to support our product claims. FORSCAR Scar Recovery Gel is a first - line treatment and prevention of old and new scars including Hypertrophic Scars, Keloids, Widespread Burn Scars resulting from Surgeries, Injuries, Burns, Insect Bites, C-Section, and Acne. Forscar is a medical device in class 1. NUTRIGROW is the first anti- hair loss treatment to show a MITOTIC EFFECT against hair loss. It stimulates proliferation of hair bulb cells in order to restart healthy and strong hair development. NUTRIGROW has a unique patented mineral/vitamin, the peptide bearing active complex formed by bonding three essential amino acids to vitamin H (Biotin). ACNEVIT is the most natural Anti-Acne formula without Salicylic Acid, Azelaic Acid and Benzoyl Peroxide. It treats acne and prevents acne formation with the anti-bacterial power of selected vitamins and herbal extracts. EPISIVA is natural hair reducer. It is not a depilatory product. It reduces the amount of unwanted hair up to 36 % in just 2 months without any pain.
Altova Healthcare group has its manufacturing setup Blossom Pharmaceuticals at Goa, manufacturing: Non-Sterile Creams, Ointments, Lotions, Gels, Ear drops, Solutions and provides Product Development Services since 1995. Backed by extensive manufacturing, marketing experience & widespread distribution network, Altova Healthcare is one of the most innovative and dynamic companies in India. The facility is WHO-GMP(India) certified and complies with US-FDA, NAFDAC and ISO 9001:2015. Our facility is registered with Srilanka and Ivory-Coast MOH.
Solutions Industry Ltd (PSI) a member of Ambah Group is the
leading sterile injectable manufacturer in Middle East and Africa.
Our manufacturing facilities in Saudi Arabia are GMP certified and equipped with the latest production technologies with over 40 years of proven reliable experience worldwide in contract manufacturing of parenteral solutions in plastic and glass bottles, plastic bags, as well as plastic ampoules.
Recently, Ambah/PSI has developed the first Ibuprofen intravenous (IV) infusion in the world (400mg/100ml). Successfully registered as Ambaprofen and Ambafen (Ibuprofen 400mg/100ml IV Infusion) through the health authorities in Germany, Spain, and Saudi Arabia, its patent has been granted by the European Patent Office (EPO patent no: 2636406) and United States Patent and Trademark Office (uspto Patent No: US 9351926 B2) for its dosage form with the approval of the European Medicines Agency (EMA).
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,500 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States. Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company markets a portfolio of branded pharmaceutical products through its Impax Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.
Ananta Medicare Ltd. specializes in manufacturing of medicines (Cephalosporins, IV Infusions and others), natural food supplements and cosmetic products. Manufacturing facilities are GMP, ISO 9001, ISO 22000, HACCP certified and situated in Italy, Japan, India. Products are manufactured in the form of parenterals, tablets, capsules, syrups, lozenges, creams, ointments and others. Company's main fields are gynecology, therapeutics, pediatrics, cardiology, urology, neurology, endocrinology, gastroenterology, cosmetology, OTC. Ananta Medicare Ltd has occupied exceptionally firm positions in the CIS countries, MENA, some EU countries since 1999.We are looking for a distributors/partners for our products worldwide. 1. Our Food supplements & Cosmetic products have many benefits:a) Clinical trials. Efficacy is clinically proven. Patented product in portfolio. b) Ready dossiers for registration.c) Developed promotional materials, trainings, mock-ups for all products. We can help you to start distribution activity very quickly.d) Our products are natural and contains herbal ingredients. e) New modern plant (2015). 2. Our own Cephalosporins plant starts operation in 2018. Total area makes about 30 thousand sq.m. New plant manufacures antibiotics of cephalosporin group (oral and parenteral forms).The plant of non-sterile medical products of different groups start to work in Shriganganagar, India too. The manufacturing and quality systems will be certified by authorized bodies of PIC/S – MHRA , FDA, etc.
ANFARM SA, a dynamic manufacturer of quality generics since 1967,
promotes its own products worldwide and acts as a third party
manufacturer for multinational companies.
- Lyophilized & Sterile products
- Cephalosporins & Carbapenems
- Non-Sterile Products
We are one of leading producers and exporters of Paracetamol API and Paracetamol DC worldwide and contract manufacturer of Paracetamol Finish Dosage, Health Ingredients and Healthcare Products,
We can offer Paracetamol API (with COS & EDQM cGMP approval, US FDA DMF Filing and annual capacity of 24000 tons), Paracetamol DC (with Germany Government of Upper Bavaria cGMP approval, US FDA DMF Filing and annual capacity of 5000 tons), Paracetamol Finish Dosage (with oversea authority cGMP approval and annual capacity of 8 billion tablets), and ISO14001 ISO9001 OHSAS18001 Approval and EHS Certification.
Antibiotic–Razgrad AD is heir to one of the largest pharmaceutical manufacturers in Bulgaria of generic drugs.Antibiotic-Razgrad AD manufactures products under its brand name, as well as for third parties under contract manufacture agreements and currently exports its products to over 25 countries in Europe and Asia.
The mission of Antibiotic-Razgrad AD as a medicinal products manufacturer is:
Aora Health is an R&D company that creates innovative nutraceuticals for specific pathologies. Our products are designed to be recommended by Doctors. We conduct double-blind, randomized, placebo-controlled clinical studies on finished formulations, and equivalence studies against pharmaceuticals. Aora Health is an R&D leader in Digestive, Anti-Depressants, Enteral Nutrition, and Ophthalmology.
Apex Drug House is a pharmaceutical company, specialized in development, manufacturing
and marketing of Branded Generics across the globe. Apex offers a wide range of products covering various therapeutic segments . The company excelled in manufacturing Tablets, Capsules, Syrups, Ointments, Dry Powder Injections, Liquid Injections, Ophthalmic solutions and Suppositories. Apex Drug House has also created a niche with its offerings of specialty products like Lozenges, Dermaceuticals, Aerosols, Mosquito Repellents, and Condoms.
Our latest range of products offers complete range of Feminine Wellness Products like Intimate wash, Lubricating Gel, Bust Firming Cream and Foam wash. Apex also manufactures Herbal Supplements and Creams.
We focus on providing quality products and continually invest our time and resources in the quest to achieve higher levels of quality products and earned reputation from our clients. To know more about product offerings, visit us at CphI Worldwide at 90A71
Apipharma is a Croatian pharmaceutical company producing natural pharmaceutical products based on honey and bee products. The company grew from a traditional beekeeping and honey based-products business. Today, it is one of the leading producers of natural pharmaceutical products on the Croatian market mostly dedicated to the production of food supplements and cosmetics for special purposes. Apipharma is also the producer of medical devices and all products are produced in new production facility which was built by latest GMP standards. The company assortment comprises 40 products.
For over 40 years, Apotex has been a trusted name in the Canadian pharmaceutical community, providing patients with increased access to quality, affordable medicines. A global company, we operate distinct lines of business including Global Generics (with 300+ prescription and OTC drugs in over 4000 doses and formats), Apotex Pharmachem (with 200+ API's developed for major markets), Apobiologix for biosimilars and complex molecule development, and ApoPharma for innovative medicines. Apotex Inc. offers a wide out-licensing portfolio of over 100 finished drug products and 200 active pharmaceutical ingredients (API), backed by a robust development pipeline focused on the top global generic priorities. Apotex Inc. is also interested in licensing pharmaceuticals from drug development/delivery companies who want to grow their business in the US, Canada, Caribbean, EMEA, APAC, and LATAM markets by utilizing our “Best in Class” commercial teams to sell, market and distribute their products. Since our founding, we have been dedicated to maintaining sustainable, state-of-the-art processes – processes that ensure our products meet the highest quality and safety standards in all markets. Through our unwavering commitment to excellence and innovation, we help communities across the world live longer, healthier lives.
APR Applied Pharma Research s.a. (“APR”) is a Swiss, independent Pharma company, focused in niche and rare therapeutic areas on a global basis. The Company develops and commercializes science driven, value added products in niche or rare therapeutic areas, by applying advanced pharma technologies and outstanding pharma development know-how. In particular, APR's business model is currently focused on 2 (two) pillars: (i) internally developed and financed (alone or together with our co-development partners) proprietary, value added products to be licensed to healthcare companies for their commercialization, and (ii) support to third party projects by offering added value R&D services under contract and fee for service arrangements. APR has a balanced pipeline of revenue generating branded products marketed in all major markets combined with a compelling pipeline of innovative products at different stage of development. The products developed or under development at APR range from Rx to OTC pharmaceutical products and include medical devices as well as nutritional supplements for targeted disease areas. Examples of marketed products include a patented formulation of Diclofenac for the treatment of migraine and acute pain, Nexodyn® AOS, a HClO Wound Cleanser for an optimized acute and chronic wounds care, Setofilm®, Ondansetron Oral Dispersible Film (ODF) for cancer supportive care (treatment of CINV and RINV), PKU GOLIKE®, an innovative Phenylalanine (Phe)-free medical food formula for Phenylketonuria management. The company's R&D efforts are currently focused on the development of improved treatments for rare inherited metabolic disorders, ocular diseases and rare dermatological diseases.APR has entered into licensing and partnership agreements with pharmaceutical companies in over 70 countries with international sales on a worldwide basis. The company has recently started up a direct sales and marketing organization in selected countries in rare disease products area.
AQMA.it originates from a pharmaceutical company to promote a new philosophy of care and well-being, thanks to products formulated to the highest standard of quality and efficiency.AQMA.it offers a line of high-quality nutraceuticals and cosmeceuticals all made in Italy, according to the strictest national and international regulations. Our mission at AQMA.it is to care about our clients physical and spiritual health, so every product is subjected to quality control protocols also planned for drugs. AQMA.it has designed a line of nutraceuticals and cosmeceuticals of high scientific profile, all made in Italy and supported by clinical literature.
AqVida is a German pharmaceutical company, specialized in development and production of oncology generics. A wide range of oncology products (parenteral and solid forms; MAs granted in Europe) are available for immediate MA transfer. AqVida is producing its oncology injectables in its new and innovative robotic manufacturing site in Germany.
We are Ardena, a reputable contract partner delivering drug development, manufacturing, logistics and (bio)analytical services to pharmaceutical customers globally. In parallel, we work with you to compile your regulatory dossier and to fast track your product towards compliance. Every day, we guide companies through the hurdles and challenges of drug development. Our integrated service offering helps to streamline the drug's progress to clinic and beyond. Ardena is your one source contractor for the chemical and pharmaceutical development of your valued compounds. In parallel, we provide you with full product analytical and bioanalytical support during development. Our dossier centric approach makes a difference. We work with you to compile your regulatory dossier in parallel with drug development, saving you time, identifying hurdles and fast tracking your product to compliance. We are experts in writing and formatting supporting CMC documentation.
With over 100 years of experience in dairy and more than 75 years of experience in the development and production of infant formula, Ausnutria manufactures tailor made infant nutrition for customers around the world. In addition, Ausnutria supports the growth and development of babies and children by offering premium infant formula brands Kabrita and Neolac Organic. Ausnutria works together with customers to develop and produce tailor made infant formula. Ausnutria owns five production sites in the Netherlands, in which the production of infant- and toddler nutrition is fully integrated. With these factories, Ausnutria controls the entire production chain from fresh cow's milk to infant formula. Ausnutria offers full support to the customer, ranging from infant formula production only, to full support in product development, R&D and marketing. The Ausnutria infant formula factories have enough production capacity for large international orders. In further consultation, the possibilities for smaller orders can be discussed.
Avalon Pharma is one of Saudi Arabia's fastest growing pharmaceutical companies uniquely positioned to become the next leader across Emerging Markets.
Our purpose is clear: To bring innovative solutions to patients, the medical community and healthcare providers in a quality and cost effective manner. We achieve this by a relentless focus on quality standards and by putting the interest of patients first.
Our values are strong: Our values help define who we are and the kind of company we aim to be. They are standard by which we hold ourselves accountable to each other, our customers and the patients who count on the work we do. Ethics, Compliance, Quality, Respect and Entrepreneurship are at the heart of everything we do.
And our future is bright: We see unprecedented opportunities for Avalon, its colleagues and its stakeholders to grow, create value while fully satisfying the needs of the customers we serve. Over the next 5 years, we will consolidate our leadership position in the GCC markets; expand across other Emerging Markets to emerge as an undisputed leader in the therapeutic areas we seek to dominate. In short, the best is yet to come.
Our mission is to brings modern, innovative health care to the local Saudi and regional Middle East markets. We believe that through intensive research, investment in technology, and a holistic understanding of our customers' medical needs we provide unparalleled care and solutions to a wide range of patients and afflictions.
Our three factories in Riyadh:
Avalon 1: The first plant, manufactures topical preparations such as topical creams, lotions, and other topical solutions. This factory produces suppositories and oral tablets and capsules on a small scale
Avalon 2: This factory produces mainly solutions.
Avalon 3: This plant is expected to run at the end of 2015, will work on the manufacturing of oral products on a large scale; will also produce creams and injections
AVEFLOR offers complex services starting from development of new products, their certification, purchase of raw materials and packing materials, to actual production and delivery to the customer. The company is also a holder of a certificate of the due production practices for the production of pharmaceuticals and the production takes place within “clean premises”. AVEFLOR has been producing liquid and powder aerosols since its foundation (1995). In 2007, the company extended its range of technologies by including the production of emulsions and gels in plastic containers and in BOV aerosols.
Ayrton Saunders, part of OBG Pharmaceuticals, is a UK based pharmaceutical company focused on the development and commercialisation of generic MDI and DPI respiratory products, glyceryl trinitrate sub-lingual spray for angina, and high value topical sprays and creams. We work through collaboration, licensing and partnerships to enable new product opportunities across markets worldwide.
The headquarter of AZ GROUP locates in National Health Technology Zone of Zhongshan City, Guang Dong Province, P. R. China. It covers an area of 35,000 square meters, with the convenient transportation of one hour from Hong Kong by ferry. As an international and US FDA cGMP approved company, AZ GROUP is a Sino-US joint venture integrates R&D, manufacturing, marketing and customer services, it has been dedicating to the career of human health since its establishment. The product of AZ GROUP includes Pharmaceutical Products, D-Cal Calcium Supplements, Nutraceuticals and Health Food. It has a variety of international advanced manufacturing & testing equipments and refined production technologies. Strict quality management system and the internationalized specifications have been established to ensure the product quality. Some of our products are US FDA approved and exported to the countries including U.S.A, Europe and Canada etc.
A leading pharmaceutical company engaged in R&D, manufacturing and marketing of high quality medicinal products with special focus on CVS/CNS areas. Our manufacturing sites comply with EU/FDA GMP. Ginkgolide injection is a global innovative herbal medicinal product of its kind for treatment of mild-moderate cerebral infarction. Other generic products are Enoxaparin sodium injection, pantoprazole sodium for injection, etc. Over 20 generic drugs are under development. We also provide contract manufacture service of liquid injectables, lyophilized, tablets and capsules and cooperate with firms to introduce high-end pharmaceutical products into Chinese market.Baiyu are open to any business cooperation that can bring benefits to both sides.
Bangkok Botanica Co Ltd
Our company was established in 2004 and based in Bangkok, THAILAND. We specialized in herbal products with a focus on niche areas of modern wound care. Our vision was to continuously improving on Thai Herbal Innovations to meet international standards using state-of-the-art technologies and supported with scientific information.
We had developed our products from herbal extracts with extensive R&D, the efficacy of the combination of effective ingredients, supported by clinical studies, published in medical journals such as: IWJ, JAPS, AJPP, JCDSA. Our success came from the high level of care for our customers and also the world that we shared.
Unveiling the herbal secrets for Scar Prevention - We offered various types of products, which were user friendly, scientifically and clinically proven with unique qualities
- Scar Prevention after Closed Wounds, Post Surgery, Post Burn, Median Sternotomy Incision, Cesarean Delivery
- Prevention & Reduction of Keloid and Hypertrophic Scars
- Prevention & Reduction of Stretch Mark
- New Patented Technology for Open Wounds
- First Aid for Sensitive Skin
- Natural Adhesive Remover
We are manufacturer of advance intermediates of Citicholine Capecitabine Luliconazole Imatinib Mesylate Also marketing partner for selling following APIs : Befotiamine Bicalutamide - with CEP Celecoxib Citalopram Hydrobromide Citicholine Sodium Etoricoxib Famotidine Nilutamide Pantoprazole Sodium Quetiapine Fumarate Pazopanib Abiraterone Acetate Bortezomib Busulphan / busulfan Capecitabine Cytarabine Dacarbazine Docetaxel Gefitinib Gemcitabine Imatinib Mesylate Irinotecan HCl Melphalan Paclitaxel Pemetrexed Disodium Heptahydrate Sunitinib Dasatinib Ibrutinib Biperiden HCl Colistimethate Sodium Itraconazole Luliconazole Modafinil Primidone - with CEP Suxamethonium Chloride / Succinyl choline chloride Tropicamide Eberconazole Aprepitant Moxifloxacin HCl Diltiazem HCl Racecadotril Tamsulosin HCl Enoxaparin Sodium L Asparaginase pegylated Asparaginase Liraglutide Roxadustat Oxanimod Netarsudil Mesylate Ozenoxacin Benznidazole L-Glutamine Deutetrabenazine Selexipag Lumacaftor Efinaconazole Luliconazole Azelaic Acid Besifloxacin HCl Carbidopa Carbimazole Chlorthalidone Dapoxetine HCl Docosanol Folic Acid Gabapentin Enacarbil Gemifloxacin Mesylate Ibudilast Ipragliflozin Lomitapide Mesylate Mesalamine / Mesalazine with CEP Methimazole Mirtazapine with CEP Minocycline Nitrofurantoin Ospemifene Raltegravir Potassium Strontium Ranelate Trelagliptin Tigecycline Zonisamide Telmisartan Clopidogrel Bisulphate Memantaine Pregabalin Pre-Filled Syringes of Enoxaparin Sodium 40 mg and 60 mg
Baxter Pharmaceuticals India Private Limited (erstwhile Claris Injectables Private Limited) is the Ahmedabad-based Generic Injectables Arm of Baxter. In Ahmedabad, Baxter Pharmaceuticals India Private Limited (BPIPL) formulates, fills and finishes a broad portfolio of essential generic medicines with complementary strengths in anesthesia and analgesics, critical care and renal medicines and anti-infectives in a variety of presentations including bags, vials and ampoules. Our manufacturing site is home to state-of-the-art manufacturing infrastructure, which follows the most stringent quality controls and is approved by international regulatory authorities. We are a leader in number of manufacturing technologies including Emulsion Remixing, PVC / Non – PVC bags, Glass Vials and Glass Ampoules. We have a 15-year track record of successfully launching new products around the world, with more than 50 products on-market today across the world and a pipeline of more than 100 new products in development.
BDR Group of companies has grown steadily and become a
house-hold name in the pharmaceutical Industry over the last 14 years, in both
domestic and international arenas. We are recognised as a “niche” player in
manufacturing of Pharmaceutical APIs and for our renowned new age formulations.
Core strength lies in identification of newer molecules, development and
commercialisation. The group is complemented majorly by its two companies - BDR
Pharmaceuticals International Pvt Ltd and BDR Life sciences Pvt. Ltd, each one
having stamped its own supremacy in respective fields, i.e. API and formulation
BDR Group focuses on development in 4 specialized therapeutic segments, viz. Oncology, Critical care, Gynecology & Neurology, which are its dream segments. BDR‘s philosophy of sustained growth and consolidation is achieved by strategic tie-ups with several globally renowned players
Be Pharma LTD is a company located in Ljubljana, Slovenia, EU. They hold the wholesaling license for import and export of FDF and APIs, also GMP license for EU batch release and a network of FDF, API and service sources around the globe. Be Pharma can also find you solutions in the field of marketing, business development and regulatory affairs. Flexibility in quantities, competitive prices and a flexible business model with a one-stop shop (from dossier to product on the market) is just a couple of reasons why you should check our stand. Our experts will gladly inform you about all options for co-operation.
Bespak is a leading developer and manufacturer of complex medical devices.
Our service offering can be divided into three categories: proprietary devices and technologies, scale up and industrialisation of an already-designed device, and design and commercialisation of a novel device for an existing drug.
As a high-volume manufacturer, we supply respiratory drug delivery devices, valves and actuators, injectable devices and medical check valves into major European and US markets, and our facilities are FDA-inspected and approved.
Major pharmaceutical companies work with us because of the quality of our development services and products, the technical knowledge, skills and experience in our team, our world-class facilities and our desire to build rewarding, long-term relationships based on excellent customer service.
Biem Pharmaceuticals, with headquarters in Ankara - Turkey, founded in 1989, is a privately held pharmaceutical manufacturer and distribution company focused on offering effective treatment options in Oncology, Hematology, Radiology, Ophthalmology and Transplantology fields.
Biodue SpA was founded in 1986 by Sion Fulvio Benedetti and develops manufactures and distributes Medical devices, Skin cosmetics and Dietary supplements (in solid and liquid forms). In 2017, Biodue reached a turnover above 36 Million Euros and about 170 employees. The plants and warehouses cover almost 17.000 square meters and all of them are located in an industrial area near Florence. The company has two main core businesses: the Industrial division, focused on contract manufacturing and the Brand division, focused on the commercialization and promotion of the company's own products. Within the Brad division, there are three Brands: Selerbe's portfolio, based on herbal products, promoted to pharmacies; Pharcos' portfolio, including medical devices, food supplements and cosmetics, promoted to dermatologists and Biofta's portfolio, including medical devices and food supplements, promoted to oculists/ophthalmologists. The company commercialize and promote its own products directly in Italy and through JVs in US and Latam; the company has in place agreements with local/regional partners in several geographic areas not covered directly. The company has recently developed and patented in EU and US an innovative technology - RewCap® - applicable to vaginal douche, mono-dose food supplements, drops food supplements and mono-dose medical devices. The company is registered under EC Regulation number 852/2004 and under GMP (Good Manufacturing Practices) certification. The company is also registered with the US Food and Drug Administration (U.S. FDA Registration no.10725095718). From May 2015, BioDue S.p.A. is listed on the Italian stock exchange in the AIM sector. The Company received the ISO 13485 certification for the development, manufacturing and production of medical devices.
extremely modern pharmaceutical plant, which manufactures antibiotics,
sulfonamides, compound feeds, dietary supplements, syrups, ointments and
creams, suppositories and vaginal globules. Our plants have integrated quality
assurance systems such as: GMP, HACCP, ISO 9001:2008. Moreover, one of them has
CE certificate for medical devices according to EN ISO 13485:2012 and AC 2012
and Medical Device Directive 93/42/EEC. Biofaktor performs contractual
production of medicinal products and dietary supplements for various
clients around the world.
We have successfully finished over 200 projects related both to development and manufacturing of the products of various categories.
Biofaktor has a huge possibilities and rich experience in product development, laboratory analysis, drawing up documentations and final production. Our expertise covers all major product groups, namely:
- food supplements,
- medical devices,
- OTC medicines,
- RX medicines,
We are also experienced in additional services:
- formal management of technology transfer,
- process adaptation if required,
- pilot runs,
- stability tests,
- full scale production,
- release analysis,
- tablets (various sizes, shapes, film and sugar coated),
- hard gelatin capsules (sizes: 1, 0, 00),
- granules (incl. coated granules),
- suppositories, vaginal globules,
- non sterile liquids,
- emulsions, balms
- blisters Alu/Alu,
- various containers with different pumps, applicators (incl. Oral and nasal)
sachets for: ointments, gels,
Biofarm is a leading family-owned Polish pharmaceutical manufacturer. All our products are GMP compliant and manufactured within the EU. Our portfolio of market leaders and innovative products contains over 60 prescription medicines, OTC medicines and dietary supplements. We are seeking long-term collaboration in various forms (distribution and licence in/out).
Our patented, safe and unique Acetium products, patient-friendly GastoPanel blood test and BIOHIT quick tests provide a purpose-built range for gastrointestinal diagnosis and stomach health.
Our core competence is based on
Our clinical trials are aiming at
- prevention of migraine type headache
- treatment of atrophic gastritis indications and
- smoking cessation
Biolab is one of the 10 largest pharmaceutical companies in Brazil. Biolab counts on over 2000 dynamic and entrepreneurial professionals who anticipate market needs and dedicate continuously to evolution. Biolab is committed to the future and, therefore, we invest 10% of our revenues in R&D and innovation. The strategic partnerships with companies, universities and research centers worldwide strengthen our international representation. Leader in the Brazilian market of prescription drugs in the field of cardiology, Biolab has a portfolio of over 100 products and has significant activities in the areas of gynecology, dermatology, gastroenterology, rheumatology, orthopedics, pediatrics and dermocosmetics.
Since 2010 Biotrading has been working too in the field of geriatrics, gastroenterology and oncology, and since 2015 also in sports and veterinary, by investing in R&D, innovation and high quality.
Production processes are certified and special attention is paid to the search for optimal solutions of safety, intake and practicality of the products.
Biotrading bases its production strategy on dynamism, technical and scientific innovation and on the quality of its products .
Micellar solution, a special pharmaceutical technology, is our strength point and it makes the difference of our innovative products.
Our mission is aimed to improve the well-being of the individual by offering and developing high quality and innovative food supplements.
A specific sector study that analyzed the last four financial statements deposited at the Chamber of Commerce places Biotrading in the 21st place among the 39 largest companies in the "Vitamins and Food Supplements" sector in Italy and in the 12th position among the most powerful and successful companies profit margins. Moreover, Biotrading is among the 17 companies that have increased their market value in the last year.
bitop AG, a
German company, is focused on the manufacturing and utilization of natural
protective molecules, the so-called Extremolytes.
For more than 20 years, bitop has explored and validated Ectoin®, a naturally-derived molecule with excellent membrane-stabilizing and inflammation-reducing properties for human use. Build on this experience, a portfolio of unique and natural OTC medical devices and cosmetics has been developed. bitop's greatest value lies in the scientifically proven efficacy of its products and the natural and preservative-free formulations.
Ectoin® already proved its efficacy and marketability successfully in various health & wellbeing products which treat and alleviate symptoms of diverse skin diseases (especially atopic dermatitis), cough and cold, allergies and dry epithelia. These products are marketed under brands of experienced pharmaceutical partners in more than 45 countries worldwide by now.
This year, bitop is proud to present its new ophthalmology product range including treatments for blepharitis, as well as new application forms for treatment of dry and allergic eyes. Additionally, bitop will broaden it's dermatology range with medical skin care products for the treatment of e.g. hemorrhoids, vaginal dryness, wound-healing, acne and rosacea.
bitop offers its Ectoin®-containing products on a B2B licensing basis to pharmaceutical companies worldwide.
Blau Farmacêutica, is a Brazilian multinational company and a pioneer in the development of recombinant proteins currently producing, bio-pharmaceuticals and Bio-similar selling in Brazil and several countries around the world. The hospital and pharmaceutical Blau line consists on an extensive and varied range of simple and complex products for treatment of several diseases, with 30 years of marketing focused in innovation and technology and with 5 subsidiaries at Latin America: Uruguay, Argentina, Colombia, Chile and Peru and soon will open one more subsidiary in Latin America.
BMI Korea, regardless of a short history from 2005 in Korean Pharmaceutical industry, has been rapidly growing & connecting into local, worldwide societies for “healthy life of human-being” with the industry's outstanding spotlight & concentration, which is derived from each BMI member's voluntary & creative R&D approach, non-stop challenge & passion, and young but most dynamical corporate's working environment for the future corporate's core value, to jump toward a global player. With a horizontal intergration of BMI's professional experiences, know-hows & novel technologies, BMI- Korea has been always putting all of effort, energy for development of differentiated & novel biopharmaceuticals & medical devices and beyond this, we - on behalf of all BMI members, promise to challenge our goal & dream to care for the best health of every human-being and to become a global leader in 21th century's healthcare industry.
Boryung Pharmaceutical Company, aiming to be the best not the biggest, started since 1957 and has put a strong presence in Korean market as one of TOP leading pharmaceutical companies.
Boryung has invested continually on research and development and made
continuous efforts to produce high-quality products. Lately by
new drug, Fimasartan (8th
Angiotensin Receptor Blocker over the world) with its own R&D,Boryung
is accelerating its R&D activity to become the global health care company.
Boryung has continued to expand the global network and now, it's partners and markets cover Japan, China, ASEAN, Europe, Latin America, Middle East, and Africa.
Boston Biopharma is a US-based pharmaceutical company that specializes in providing the highest quality specialty medications worldwide, in particular to emerging countries. We do this through pioneering R&D, and licensing, manufacturing, and commercializing the finest therapeutics especially oncology, multiple sclerosis, and immunology. Our EMEA operations office is located in Malta and we have a significant market presence in Algeria, Iraq, and the GCC. With a focus on product quality and operational flexibility, our firm brings decades of healthcare industry expertise to some of the most difficult markets.
Bright Way Group is one of the leading Russian pharmaceutical company. We have 20 years of experience in the market as distributor of the Active Pharmaceutical Ingredients at the territory of Russian Federation; Over than 200 APIs had been registered at the Russian Federation by our side, we successfully realized a lot of commercial sales and have a positive relationship with reliable partners globally. We have our own Office as well as Registration Bureau and warehouse facilities; At present we are also involved in several governmental projects. We are actively working to expand the business and at the moment we have our own production plant of Finished Formulations, and we realize the project of building a new plant in the Moscow region. The project is implemented with the active support of the Russian government. We are looking for partnerships that can create new opportunities for business expansion in other countries and regions. Our main activities are: Promotion and Distribution of APIs, FDF, veterinary medicines, equipment, cosmetics. Production of FDF in Russia. Contract manufacturing. Localization of FDF production in Russia. Technology transfer. Localization of API production in Russia. Manufacturer/supplierFinished Dosage FormulationCountries: Russia - EuropeFinished Dosage FormulationCountries: Russia - Europe FDFContract ServicePharmaceutical Services Countries: Russia - Europe Packaging and LogisticsCountries: Russia - Europe
Established in 1997, Bristol Laboratories is a fast growing British pharmaceutical company engaged in the development, manufacture, marketing and distribution of generic medicines in the UK and Europe.
We are a global leader with 100 years experience in the research, development and manufacturing of high-grade activated carbon as purification aid in the pharmaceutical and other industries. Our powdered, granular and extruded activated carbons are used for the removal of colors, odors, by-products, traces of catalyst or any other impurities that aren't allowed in the final product. Under the NORIT® brand we produce medicinal products based on activated carbon including contract manufacturing. We meet the most stringent quality requirements that guarantee consistency in performance and purity. Our specialists can support you selecting the best activated carbon for your process in the early drug development phase, scaling up and full production.